Premium
People with low immune response will be immunized against COVID from the first scheme with three doses of vaccine, the chairman of the National Committee for Coordination of Vaccination Activities against COVID-19, Valeriu Gheorghita said on Wednesday.
According to him, the additional dose in the initial scheme recommended for people with low immune response is administered at 28 days for both the BioNTech Pfizer vaccine and the Moderna vaccine.
He said that they will be updated to allow the introduction of a three-dose vaccination scheme for both the National Electronic Vaccination Registry and the appointment platform.
